Drug Trial Radar · NCT06559163
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
190
Actual
Start
Sep 17, 2024
Primary completion
Sep 23, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Zenas BioPharma (USA), LLCIndustry
- Sponsor type
- Industry
- First posted
- Aug 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).
Conditions
- Systemic Lupus Erythematosus
Interventions
ObexelimabDrug
Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRllb, resulting in down regulation of B cell activity.
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Outcome MeasureTime frame: 24 weeks
Locations
110 sites in 18 countries. Site status is shown where the registry gives one.
Onyx Clinical Research
Peoria, Arizona
Sierra Pacific Arthritis and Rheumatology Centers
Fresno, California
California Research Institute
Huntington Park, California
University of California, San Diego
La Jolla, California
University of California, Los Angeles
Los Angeles, California
Solace Clinical Research
Tustin, California
Yale University
New Haven, Connecticut
Clinical Research of West Florida, Inc
Clearwater, Florida
Clinical Research of West Florida, Inc.
Tampa, Florida
Emory University
Atlanta, Georgia
AARA Clinical Research - Chicago Arthritis & Regenerative Medicine
Chicago, Illinois
Orthoillinois
Rockford, Illinois
Willow Rheumatology and Wellness
Willowbrook, Illinois
Accurate Clinical Research
Lake Charles, Louisiana
Axon Clinical Research
Baltimore, Maryland
UMass Chan Medical School
Worcester, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Juno DO, PC
Lansing, Michigan
Revive Research Institute - Sterling Heights
Sterling Heights, Michigan
Velocity Clinical Research
St Louis, Missouri
Hospital for Special Surgery
New York, New York
SUNY Upstate Medical University
Syracuse, New York
DJL Clinical Research PLLC
Charlotte, North Carolina
Cross Creek Medical Clinic
Fayetteville, North Carolina
Onsite Clinical Solutions
Salisbury, North Carolina
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma
Penn State - Hershey Medical Center
Hershey, Pennsylvania
AARA Clinical Research - Rheumatology Specialty Center
Willow Grove, Pennsylvania
Prolato Clinical Research Center (PCRC)
Houston, Texas
Accurate Clinical Research
Houston, Texas
Prime Clinical Research - Lewisville
Lewisville, Texas
Prime Clinical Research - Mansfield
Mansfield, Texas
UZ Leuven
Leuven, Belgium
CHU de Liege
Liège, Belgium
Medical Center Medtech Services EOOD
Haskovo, Bulgaria
University Multiprofile Hospital for Active Treatment "Eurohospital Plovdiv"
Plovdiv, Bulgaria
Diagnostic Consultative Center Convex EOOD
Sofia, Bulgaria
Richmond Clinical Trials
Richmond, British Columbia, Canada
Riverside Professional Centre
Sydney, Nova Scotia, Canada
The Second Affiliated Hospital of Soochow University
Suzhou, China
Showing 40 of 110 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.